MODERN OSTEOARTHRITIS THERAPY: ALFLUTOP IN CLINICAL PRACTICE, EXPERIMENTALANDCLINICAL DATA

Медицинский совет

N. V. Chichasova¹ 

[1] Institute of Vocational Education, Sechenov First Moscow State Medical University;

关键词: osteoarthritis;    cytokines;    metalloproteases;    oxidative stress;    alflutop;    clinical effectiveness;   

DOI  :  10.21518/2079-701X-2017-17-138-145

来源: DOAJ

【 摘 要 】

The article discusses experimental data that demonstrated the ability of Aflutop to stimulate proliferation and regeneration of chondrocytes, to inhibate in vitro extracellular release of IL-6 cytokine and IL-8 chemokine compared to control cells, to inhibit VEGF, a proangiogenic factor, a biochemical proactive factor in destructive processes of OA, as well as the proven existence of the antioxidant activity of Alflutop. The data of numerous clinical studies (including the double blind placebo-controlled) show that it has an expressed analgesic effect, developing in the first weeks after administration in osteoarthritis patients, including with periarthrites, osteochondrosis, with back pain of different genesis, and the existence of the anti-inflammatory effect and a positive impact on the quality of life of osteoarthritis patients. At a high evidentiary level, the structural modifying effect of Alflutop and its safety is confirmed.

【 授权许可】

Unknown